49 results about "Cellular density" patented technology

The invention discloses tissue cell activity detection equipment, and relates to the technical field of cell activity detection.The tissue cell activity detection equipment comprises a detection box, a box door is hinged to the outer wall of one side of the detection box, and a culture plate is slidably connected to the bottom of an inner cavity of the detection box; at least four sliding grooves are symmetrically formed in the inner wall of the detection box, a detection person pulls an operation handle to promote a connecting base to slide along the surface of a limiting column, a gear is meshed with a plurality of racks to promote the gear to drive a liquid storage tank to rotate by 180 degrees in a reciprocating mode, and then cell suspension is continuously shunted through a plurality of stop levers. Therefore, the liquid storage tank can be continuously rotated when the cell suspension is dripped, so that the cell suspension can be prevented from being in a static state for a long time to generate a precipitation phenomenon, the cell density distribution of the cell suspension in the holes in the culture plate can be ensured to be uniform, the accuracy and the reliability of a detection result can be improved, and the detection efficiency is improved. The quality of detection data can be improved, and meanwhile, the time and the cost of repeated detection due to inaccurate detection results are reduced.

The invention relates to the technical field of image analysis, in particular to a data visualization pathological diagram analysis system which comprises a pathological image noise reduction and enhancement module, a lesion area judgment module, a local texture and global structure fusion module, a self-adaptive multi-scale segmentation module and an error correction and optimization module. According to the method, by analyzing color channels, cell structure edge features and background noise distribution in the pathological image, accurately screening noise and optimizing image filtering, the image quality is effectively enhanced, the noise is reduced, the recognition accuracy of a lesion area is improved, and the recognition accuracy of the lesion area is improved in combination with cell nucleus gradient information and tissue edge distribution. The accuracy is further improved by using gray statistics and cell density, region division is weighted and optimized through the contrast and entropy of lesion tissues, the segmentation accuracy is ensured, the image segmentation scale is accurately adjusted in combination with the cell density and color gradient information, errors are reduced, accurate segmentation of lesion regions is ensured, and the accuracy of image segmentation is improved. And finally, the precision and reliability of overall image analysis are improved.

The invention belongs to the technical field of bioengineering, and particularly discloses an in-vitro amplification method of canine NK cells capable of efficiently killing tumor cells and application of the canine NK cells. 3 mL of dog peripheral blood is taken, and dog peripheral blood mononuclear cells PBMC are obtained through separation; activating, amplifying and culturing canine NK cells capable of efficiently killing tumor cells; and collecting the amplified canine NK cells capable of efficiently killing the tumor cells, and storing the canine NK cells in a cryopreservation solution according to the cell density of 1 * 10 < 8 > cells / mL. According to the method, the canine NK cell with high amplification multiple can be obtained by only needing 3mL of canine peripheral blood, and the amplification multiple is high; the number of the dog NK cells of the healthy volunteer dog sample is 3.02 * 108, the amplification multiple is 1008, the total number of the dog NK cells of the tumor volunteer affected dog sample reaches 6.84 * 107, and the amplification multiple is 340; and the canine NK cell obtained by the invention has the effect of efficiently killing tumor cells.

The invention relates to a Vero cell serum-free culture medium and application thereof, the serum-free culture medium is suitable for free suspension growth of Vero cells and is free of animal sources and protein components, adherent cells can be directly domesticated through a certain method to screen out Vero suspension cells, and serum-free suspension culture of the Vero suspension cells is achieved in the serum-free culture medium. The density of cells subjected to suspension culture by adopting the serum-free culture medium can reach more than 107 cells / mL, the cell viability is more than 90%, the cells are well dispersed, the cells can still normally grow and proliferate after continuous subculture for 20 generations, and the cells are sensitive to various viruses.

A method includes introducing a suspension including cells suspended in a cell culture medium through a feed port or a drain port into a cavity of a cell culture vessel, the suspension being in an amount sufficient to cover a gas permeable, liquid impermeable membrane positioned at a bottom of the cell culture vessel, the feed port being disposed through a surface of the cell culture vessel and configured to permit additional cell culture medium into the cavity, and the drain port being disposed through the surface of the cell culture vessel and configured to permit removal of the cells, cell culture medium, and used cell culture medium from the cavity, allowing the cells to settle on the gas permeable, liquid impermeable membrane by gravity, removing the used cell culture medium through the drain port and introducing the additional cell culture medium through the feed port such that a constant volume is maintained in the cell culture vessel until the cells expand to a desired cell density, wherein the removing and introducing are performed subsequent to allowing the cells to settle on the gas permeable, liquid impermeable membrane, resuspending the cells in the cell culture medium in the cell culture vessel, wherein the resuspending is performed after the desired cell density is attained, and removing the resuspended cells and the cell culture medium through the drain port.

The invention relates to the technical field of medical image processing and artificial intelligence cross application, in particular to a medical image detection method based on a cross-channel and cell density adaptive mechanism. According to the method, on the basis of a YOLO backbone architecture, a cell density adaptive attention module, a cross-channel feature enhancement module and a multi-magnification detection head are introduced, and a multi-dimensional cooperative enhancement detection network model is constructed and formed; and accurate detection and semantic feature enhanced characterization of medical targets in scenes with different tissue cell densities, different target scales and different image magnification factors are realized. According to the technical scheme, through core mechanisms of cell density adaptive modeling, cross-channel feature interaction, hierarchical feature fusion and the like, the technical problems of insufficient detection stability, weak model generalization ability, insufficient target semantic feature expression and the like in the existing medical image detection technology are effectively solved; finally, high-precision, low-delay and high-expandability pathological image automatic detection is realized.

The invention relates to the technical field of biological information processing, in particular to a CIK cell preparation method and system.The CIK cell preparation method comprises the following steps that cell density data of a time sequence is collected, an autocorrelation function value and a partial autocorrelation function value are calculated, a first-order difference sequence and a second-order difference sequence are extracted, ADF statistics and KPSS statistics are calculated according to the difference sequences, and the CIK cell density data is obtained. And comparing the statistical magnitude range to judge the stationarity of the time sequence, and generating stationary cell density sequence data. According to the method, through extraction and optimization of the lag correlation value and the partial correlation value, the accuracy of model parameters is enhanced, reliable support is provided for dynamic correction and conjoint analysis of the future cell proliferation rate, abnormal points are accurately recognized based on analysis of the difference mean value and the weighted accumulation value, the anomaly detection efficiency is remarkably improved, and the method is suitable for large-scale popularization and application. Dynamic adjustment of culture conditions is realized by combining abnormal point indexes and drifting rate calculation of environmental parameters, the influence of environmental fluctuation on cell proliferation quality is reduced, and preparation quality and efficiency are guaranteed.

The invention discloses a urine detection method based on lensless microscopic lamination imaging, which comprises the following steps of: acquiring a low-resolution image of a urine sample by using a lensless microscopic lamination imaging device, calculating an incident wave vector to obtain a light field, and performing Fourier transform on the light field; smooth processing is carried out through Gaussian filtering, and image enhancement is carried out through Laplacian sharpening; using the low-resolution image to obtain a final large-view-field high-resolution image through iterative updating; adaptive threshold segmentation is carried out on the image, and then cells and a background are separated to obtain a segmented image; performing edge detection on the image by using a Canny operator to output the image; carrying out edge detection on each pixel point by using a non-maximum suppression method, and segmenting by using double thresholds; and performing cell counting on the image after edge detection, calculating the cell density, and finally outputting the identified and calculated information. The improvement of the method is expected to promote wide application of lensless microscopic lamination imaging in urine detection.

The invention discloses a preparation method and application of a chimeric antigen receptor NK cell, and relates to the technical field of immunization, and the preparation method comprises the following steps: (1) recovery of a peripheral blood mononuclear cell (PBMC); (2) sorting NK cells; (3) carrying out multiplication culture on the sorted NK cells; (4) adding cell factors into the NK cells subjected to multiplication culture, and performing activation culture; the cell factor is a combination of IL-2 (Interleukin-2), IL-15 and IL-21 (Interleukin-21); and (5) adding Polybrene into the activated and cultured NK cells, infecting for 2-24 hours by using lentivirus carrying CAR molecules and having MOI of 1-10 virus amount according to the cell density of 2 * 10 < 5 >-1 * 10 < 6 > / mL, changing the liquid after infection, and continuously culturing for 54-72 hours to obtain the chimeric antigen receptor NK cells. According to the invention, the optimized conditions are utilized to prepare the CAR-NK cells, and the CAR positive rate can reach 93.87%.

The invention relates to the technical field of medical data processing, and discloses a cancer immunotherapy prognosis prediction method, system and equipment based on CD8 + T cell density in a necrotic area and a medium. The method comprises the following steps: firstly, extracting pathological features on a CD8 immunohistochemical staining (IHC) slice image of tumor tissue of a to-be-detected person after neoadjuvant immunotherapy by using a multi-scale feature extraction model, and then carrying out regional division on the CD8 IHC slice image by using a regional classification model to obtain a necrotic region; then, the CD8 + T cells in the necrotic area are recognized and counted through the target recognition model, the cell density of the CD8 + T cells in the necrotic area is rapidly obtained, and finally, the EFS of the person to be detected is accurately predicted based on the cell density of the CD8 + T cells in the necrotic area. According to the method, efficient and high-precision EFS prediction can be carried out only through the CD8IHC slice image of the tumor tissue, and a doctor can make a proper diagnosis and treatment plan for a patient according to a prediction result.

The invention provides a high-density suspension transfection method for efficiently obtaining a lentiviral vector. The method comprises the following steps: accurately regulating and controlling the density of HEK293T cells to 5.5-6.5 * 10 < 6 > cells / ml, mixing GOI, pL-Gagpol, pL-Rev and pL-VSVG plasmids according to a molar ratio of 4: 2: 1: 0.6, and forming a transfection compound according to a ratio of PEI to total plasmids of 2.5: 1; and after transfecting for 24 hours, adding 5 mM of sodium butyrate, and continuously culturing for 72 hours to obtain the virus. According to the method, the traditional density limitation is broken through, the transduction titer is increased by 3 times when the density is 6 * 10 < 6 > cells / ml, special equipment is not needed, and the production cost is greatly reduced. The produced lentiviral vector is suitable for the field of gene therapy such as CAR-T cell therapy, the titer of the lentiviral vector is larger than or equal to 2.5 * 10 < 7 > TU / ml, and refractory target cells can be efficiently transduced.

This invention relates to the field of nucleic acid detection technology, specifically disclosing a liquid-phase nucleic acid chip for isothermal amplification of common algal blooms and its application. The method includes: collecting water samples and filtering to enrich algal cells; lysing the algal cells using cell lysis buffer to extract DNA; adding the extracted DNA to the liquid-phase nucleic acid chip for isothermal amplification; detecting the Ct value using a qPCR instrument; and determining the species and cell density of the algal bloom based on a preset standard curve. This invention directly quantifies algal cell density using algal gene copy number, with significantly higher accuracy than microscopic counting, and does not rely on the experience of professional personnel. It can be widely applied in frontline water resource management work.

An image processing using a plurality of specimen images obtained by successively applying a plurality of types of staining to a specimen to be evaluated and imaging the specimen after staining for at least two types of staining is performed. The image processing comprises: extracting an inner region corresponding to inward of a cell membrane of a single cell in the specimen based on at least one of the specimen images; specifying a cell region corresponding to an individual cell included in the specimen by expanding the inner region outwardly; and performing image cytometry for the cell region based on the specimen images. In analyzing a pathological specimen on a cell-by-cell basis, it is possible to deal with multiple immunostaining and specify the positions of individual cells and evaluate each cell separately even when a cell density in the specimen is high.

The present invention discloses a method for preparing chimeric antigen receptor NK cells and its application, which relates to the field of immunotechnology and includes: (1) resuscitation of peripheral blood mononuclear cells PBMC; (2) NK cell sorting; (3) amplifying and culturing the sorted NK cells; (4) adding cytokines to the amplified and cultured NK cells for activation culture; the cytokines are a combination of IL-2, IL-15 and IL-21; (5) adding Polybrene to the activated and cultured NK cells, and infecting with lentivirus carrying CAR molecules at a virus dose of MOI 1-10 for 2-24 h at a cell density of 2×10 5 ~1×10 6 cells / mL, changing the medium after infection, and continuing to culture for 54-72 h to obtain chimeric antigen receptor NK cells. The present invention uses the optimized conditions to prepare CAR-NK cells, and the CAR positive rate can reach 93.87%.

The invention discloses an NK (Natural Killer) cell in-vitro amplification culture method which comprises the following steps: on the 0th day, inoculating mononuclear cells into a culture bottle containing an NK cell culture solution, autologous plasma and an exosome of HEK293 cells, and standing and culturing in an incubator for 14 days; during the culture period, supplementing the NK cell culture solution and the autologous plasma once every two days, and controlling the cell density to be 1.0 * 10 < 6 > cells / mL; wherein the exosome of the HEK293 cell also needs to be supplemented on the seventh day; and after 14 days of culture, collecting centrifugal cells to obtain the NK cells. According to the culture method, the exosome of the HEK293 is used for replacing trophoblast cells added in the process of culturing the NK cells by a feeder method, so that the safety risk possibly caused by directly using the trophoblast cells is reduced; meanwhile, the HEK293 exosome is added and is combined with the NK cell surface receptor, so that synergistic stimulation is provided, the NK cells are activated and amplified at a high speed, and the multiplication capacity and purity of the NK cells are greatly improved.

The present invention relates to a bone marrow fluid analysis method, a sample analysis device, and a recording medium containing a program. The present invention provides a means for obtaining an index related to bone marrow nucleated cell density by measuring nucleated cells and lipid particles in bone marrow fluid. By counting the number of nucleated cells and lipid particles in bone marrow fluid and obtaining an index related to bone marrow nucleated cell density based on the nucleated cell and lipid particle counts, the aforementioned technical problems are solved.

An observation device according to the present disclosure is for observing the state of a cell population comprising of a plurality of cells. The observation device comprises: at least one irradiating unit which is disposed in a position facing the cell population, and which irradiates at least one irradiation region set in the cell population with irradiating light having at least one wavelength included in the ranges of 650 to 850 nm and 1060 to 1090 nm; at least one light receiving unit which is disposed in a position facing the cell population and which receives emitted light emitted from the cell population as a result of the irradiation of the irradiation region with the irradiating light; and an analyzing unit which is communicably connected to the light receiving unit, and which obtains, on the basis of the intensity of the emitted light, a parameter that includes at least one of the number of cells and the cell density of the cell population in the irradiation region.

The application belongs to the technical field of bioengineering, and specifically discloses an in-vitro expansion method and application of dog NK cells with high tumor cell killing efficiency, which comprises the following steps: recovering K562 engineering cells stored by freezing in sequence; taking 3 mL of dog peripheral blood to obtain dog peripheral blood mononuclear cells (PBMC); activating and expanding culture of dog NK cells with high tumor cell killing efficiency; collecting the expanded dog NK cells with high tumor cell killing efficiency, and storing them in a freezing medium at a cell density of 1×10 8 The application can obtain dog NK cells with high expansion multiple from only 3 mL of dog peripheral blood; the number of dog NK cells of a healthy volunteer dog sample is 3.02×10 8 after 11 days of continuous expansion culture, and the expansion multiple is 1008; the total number of dog NK cells obtained from a tumor volunteer dog sample reaches 6.84×10 7 , and the expansion multiple is 340; and the dog NK cells obtained by the application have high tumor cell killing efficiency.

The invention relates to the technical field of cell culture, and particularly discloses an integrated esophageal cancer tumor cell culture and separation system which comprises a box body and an auxiliary assembly, the auxiliary assembly comprises a fixing frame arranged in the box body, a side plate is slidably clamped on one side of the box body, the fixing frame is connected to the side, close to the box body, of the side plate, and a plurality of clamping grooves are formed in the fixing frame; a culture bottle is clamped in each clamping groove, a sealing cover is rotationally clamped at one end of each culture bottle, a limiting groove is formed in the box body, a sliding plate slides in the limiting groove, and a clamping assembly is arranged on the sliding plate; an auxiliary assembly arranged in the device can assist an experimenter in adding a culture medium, digestive juice and other experimental solutions into the culture bottle when the cell density in the culture bottle reaches the passage critical density, when the device is used for cell culture, after tumor cells are inoculated into the culture bottle, the culture bottle is clamped into a clamping groove formed in a fixing frame, and the culture bottle is fixed through the clamping groove. The growth condition of the tumor cells in the box body can be observed through the observation window by translating the sliding plate arranged in the limiting groove.

The invention relates to the technical field of disease treatment drugs, and discloses application of mesenchymal stem cells in drugs for treating acute graft versus host disease, the drugs and a preparation method of the drugs, and the mesenchymal stem cells are derived from KRT8 + subgroups; the medicine comprises mesenchymal stem cells from a high-expression KRT8 < + > subgroup and pharmaceutically acceptable auxiliary materials, the culture method of the mesenchymal stem cells comprises the following steps: separating KRT8 < + > subgroups from human tissues, placing the KRT8 < + > subgroups in a 4-6% carbon dioxide incubator at 35-39 DEG C, and culturing the KRT8 < + > subgroups in DMEM / F12 added with 8-12% of fetal calf serum; then, in a 4-6% CO2 culture box at the temperature of 35-39 DEG C, culturing in RPMI-1640 added with 8-12% of FBS and 0.03-0.07 mM 2-Mer; and when the cell density reaches 70-90%, dissociating the cells by using trypsin. According to the invention, the anti-leukemia (GVL) activity of the graft can be maintained while aGVHD is prevented.

The invention discloses a method for detecting the peony pollen cell oxygen consumption rate by using a cell energy metabolism analyzer, and belongs to the field of plant cell mitochondrial function detection. The method comprises the following steps: hydrating a probe plate and a coated cell culture microwell plate in advance, preparing a basic culture medium, preparing a pollen suspension, fixing pollen cells, dosing the probe plate and calibrating on a machine, culturing the fixed pollen cells in a CO2-free incubator at 37 DEG C for 1 hour, testing on the machine, and setting a time program for measuring a cycle. And taking out the probe plate and the cell culture microwell plate after the test is completed, and analyzing the result by using Wave software. A standard process for detecting the mitochondrial function by using a Seaharse XFe96 cell energy metabolism analyzer is created aiming at cells or tissues such as plant cells which cannot grow in a wall-adhering manner, the used cell adhesive is economical and convenient to prepare, and the cell density, the dosing concentration and the determination procedure are optimized aiming at the characteristics of the peony pollen. And a solid foundation is laid for carrying out pollen mitochondrial biological energy and cell metabolism analysis.

A method includes introducing a suspension including cells suspended in a cell culture medium through a feed port or a drain port into a cavity of a cell culture vessel, the suspension being in an amount sufficient to cover a gas permeable, liquid impermeable membrane positioned at a bottom of the cell culture vessel, the feed port being disposed through a surface of the cell culture vessel and configured to permit additional cell culture medium into the cavity, and the drain port being disposed through the surface of the cell culture vessel and configured to permit removal of the cells, cell culture medium, and used cell culture medium from the cavity, allowing the cells to settle on the gas permeable, liquid impermeable membrane by gravity, removing the used cell culture medium through the drain port and introducing the additional cell culture medium through the feed port such that a constant volume is maintained in the cell culture vessel until the cells expand to a desired cell density, wherein the removing and introducing are performed subsequent to allowing the cells to settle on the gas permeable, liquid impermeable membrane, resuspending the cells in the cell culture medium in the cell culture vessel, wherein the resuspending is performed after the desired cell density is attained, and removing the resuspended cells and the cell culture medium through the drain port.

There is provided a system and method for generating a mapping of local brain cell activity and connectivity. The method including: receiving brain imaging data from image captures of a brain; generating a binary segmentation map using a trained deep learning model, the deep learning model taking the brain imaging data as input; performing registration of the brain imaging data to a brain template; voxelizing the segmentation map and warping the voxelized segmentation map using deformations obtained during registration; determining group-wise heatmaps of neuronal density or cellular density from the voxelized and warped segmentation map; generating a map of clusters of between-group differences in neuronal density or cellular density from the group- wise heatmaps of the voxelized and warped segmentation map; and outputting the map of clusters as a representation of local brain cell activity and connectivity.

The invention discloses a method for simultaneously extracting various cells of internal and external secretion parts of pancreas, and relates to the technical field of pancreas islet separation and purification. The invention discloses a method for simultaneously extracting various cells of internal and external secretion parts of pancreas. The method comprises the following steps: exposing a target visual field, performing pancreas perfusion, terminating digestion, sieving, performing gradient centrifugation, observing and separating layered cells, sorting pancreas islets, extracting acinus cells and identifying. According to the method, a gradient centrifugation method is adopted, a density gradient environment is constructed through a gradient centrifugation solution based on the difference of different cell densities, and various cells settle to corresponding positions according to self densities, so that efficient separation of islet cells, alveolar cells and impurities (such as adipocytes, digestive enzymes and tissue fragments) is realized, and the separation efficiency of the islet cells, the alveolar cells and the impurities is improved. Finally, different types of cells are obtained, and various cell populations obtained based on the method are high in purity, good in activity and high in yield.

The present invention relates to the technical field of bioinformatics processing, and specifically to a method and system for preparing CIK cells, comprising the following steps: collecting cell density data in a time series, calculating autocorrelation function values and partial autocorrelation function values, extracting first-order and second-order difference sequences, calculating the ADF statistic and the KPSS statistic based on the difference sequences, comparing the statistic ranges to determine the stationarity of the time series, and generating stationary cell density sequence data. In the present invention, through the extraction and optimization of lag correlation values and partial correlation values, the accuracy of model parameters is enhanced, providing reliable support for the dynamic correction and joint analysis of the future cell proliferation rate. Based on the analysis of difference means and weighted cumulative values, abnormal points are accurately identified, significantly improving the efficiency of anomaly detection. Combining the abnormal point index and the drift rate calculation of environmental parameters, the dynamic adjustment of culture conditions is realized, reducing the impact of environmental fluctuations on the quality of cell proliferation, and ensuring the preparation quality and efficiency.

The invention provides a composition as well as a preparation method and application thereof, and belongs to the technical field of biological materials. The composition comprises a first component and a second component, the first component is polyethylene glycol NHS-PEG-NHS with N-hydroxysuccinimide ester groups at two ends, and the second component is random copolymerization polypeptide formed by random copolymerization of serine and lysine. The hydrogel composition formed by the NHS-PEG-NHS and the random copolymerized polypeptide can effectively resist protein adsorption and cell attachment due to the strong hydrogen bond hydration effect formed by amido bonds on a main chain and hydroxyl groups on side chains, and has the antifouling characteristic, so that foreign matter reaction resistance and in-vivo foreign matter reaction resistance are achieved. When the hydrogel composition is added into cells for encapsulation, amino groups on the surfaces of the cells and amino groups on side chains of the copolymer are covalently bound by utilizing NHS-PEG-NHS to construct a high-strength hydrogel network, and the strength of the hydrogel composition is regulated and controlled by the density of the encapsulated cells.

The invention relates to a method for determining the prognosis of a patient diagnosed with cancer, the method comprising: - obtaining from the patient a histology section containing a tumour area; - in a measurement step, contacting the histology section with a labelled probe capable of specifically labelling T cells, and obtaining an image of the tumour area, - in an image analysis step, quantifying the density of T cells present per mm2 in at least 2 separate, non-overlapping regions of the image of the tumour area; - calculating a dispersion value (alpha); and - assigning the patient a high probability of survival if the dispersion value is below a threshold value; or a low probability of survival if the dispersion value is above the threshold value.

This cell observation device comprises: an imaging device that captures an image of a cell contained in a cell suspension flowing through a flow path; a density detection mechanism for detecting the density of cells in the cell suspension; a dilution mechanism for diluting the cell suspension in the flow path; and a processor for diluting the cell suspension to control the density of the cells to a preset target density as a density suitable for imaging by the imaging device.

An image depicting a tissue sample is received. One or more tissue compartments present in the image of the tissue sample are identified including by generating a compartment map identifying pixels in the image depicting the tissue compartments. One or more cells present in the image of the tissue sample are identified including by generating a cell map identifying pixels in the image depicting the cells. A density-based pathology signature for the image of the tissue sample is determined based on the compartment map and the cell map. The density-based pathology signature includes a density of each cell type present in the one or more tissue compartments. A response computation model is applied to determine, based on the density-based pathology signature, a predictive output indicative of a likelihood of a patient associated with the tissue sample responding to an anticancer therapy such as immunotherapy.

The invention provides a composite additive and application thereof in mammalian cell culture, and relates to the technical field of cell culture, the composite additive comprises a pyrimidine nucleoside precursor, vitamin, amino acid, a TCA circulation intermediate product and metal ions; wherein the deoxyuridine is used as a pyrimidine nucleoside precursor and can promote cell DNA synthesis so as to improve the peak living cell density; pyridoxine hydrochloride and choline chloride synergistically regulate amino acid metabolism and enhance the antibody synthesis efficiency; magnesium is an activating agent of mitochondrial key enzymes such as pyruvate dehydrogenase and citrate synthase and can improve the ATP generation efficiency and provide more energy for antibody synthesis, alpha-ketoglutaric acid optimizes tricarboxylic acid circulation to supply energy, the cell activity in a low-iron environment is guaranteed, finally, multi-channel synergistic interaction is achieved, the cell density and the antibody yield are improved, and the product quality is improved. And the key quality attribute of the antibody is not changed. The technical problem that a culture medium in the prior art cannot coordinate the balance of cell density, antibody yield and charge heterogeneity in a low-iron environment is solved.